Location: Home
  • search
  • go
  • Relate News
  • 11/6/2024BioCity Presents Late-Breaking Phase 2 Results for IgA Nephropathy Tre...
  • 11/6/2024Pharma Firms Present Innovative Treatments for Major Diseases at CIIE
  • 11/6/2024MNCs and Chinese Partners Join Forces to Build an Innovative Healthcar...
  • 11/5/2024Aurobindo Challenges China in the Global Penicillin G Market with New ...
  • 11/1/2024Merck Faces Gardasil Sales Challenges in China, Impact Expected to Con...
  • 10/31/2024CirCode Advances Gene Therapy with HM2002 IND Approval
  • 10/29/2024Clover Announces Positive Results for RSV Vaccine SCB-1019 vs GSK's AR...
  • 10/25/2024China Expands Free HPV Vaccination to Reach 40% of Eligible Girls
  • 10/24/2024Sinopharm and Chinese Vaccine Makers Slash Prices Amid Fierce Market C...
  • 10/24/2024CASI Granted Chinese CTA Approval for CID-103 in Immune Thrombocytope...
  • 10/21/2024Changing Chinese Market Dynamics Hit Merck Where It Hurts (SCRIP Citel...
  • 10/15/2024Review of Online Drug Sales Growth in China 2021-2023
  • 10/11/2024CanSino Receives Over $17M from Gates Foundation to Accelerate Polio V...
  • 10/11/2024Chinese Health Insurance Premium Income Up 4.5% in 2023
  • 10/2/2024Publication Announcement on the Inclusion of Marstacimab as Pilot Proj...
  • 10/1/2024Akeso's Ebronucimab (PCSK9) Approved for Hypercholesterolemia in China
  • 9/26/2024CDE Issues the Technical Guidelines for Vaccine Immunogenicity Bridgin...
  • 9/13/2024Fosun Pharma to Acquire Full Ownership of Fosun Kite and Strengthens P...
  • 9/12/2024Innovent's Mazdutide Outperforms Trulicity in Phase III Type 2 Diabete...
  • 9/11/2024China to Implement Comprehensive Measures to Enhance Insurance Sector ...
  • 9/9/2024Akeso, Summit's PD-1 Bispecific Beats Merck's Keytruda in China-Only S...
  • 9/3/2024CDE Solicits Comments on Draft of the Technical Guidelines for Vaccine...
  • 8/30/2024Jacobio Out-licensed KRAS G12C Inhibitor Glecirasib and SHP2 Inhibitor...
  • 8/29/2024CDE Solicits Comments on Draft of the Technical Guidelines for Non-Cli...
  • 8/28/2024CDE Solicits Comments on the Technical Guidelines for Non-Clinical Eff...
  • 8/28/2024CDE Solicits Comments on the Technical Guidelines for Clinical Trials ...
  • 8/27/2024Legend Biotech Wins Chinese Approval of CAR-T Carvykti (Cilta-cel)
  • 8/27/2024Sanofi Suspends Supply and Sale of Flu Vaccine in China
  • 8/26/2024CDE Solicits Public Comments on the Technical Guidelines for Pharmaceu...
  • 8/26/2024Chinese Pharma Cos Set Sights on Dominating Therapeutic Cancer Vaccine...
  • Page:3/71 Total number of articles:2126: [First][<<] [1] [2] [3] [4] [5] [>>] [End]
  • Site map | Contact Us | Links
  • © Wicon International Group